CYT

Cyteir Therapeutics, Inc. Common Stock

Delisted

CYT was delisted on the 15th of March, 2024.

30 hedge funds and large institutions have $28.5M invested in Cyteir Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 10 closing their positions.

Holders
30
Holders Change
-7
Holders Change %
-18.92%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
7
Reduced
12
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
LC
26
Lindbrook Capital
California
$3.31K
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$1K -$3.1K -1,536 -76%
Citigroup
28
Citigroup
New York
$406 -$698 -423 -63%
Wells Fargo
29
Wells Fargo
California
$160 +$5 +3 +3%
UBS Group
30
UBS Group
Switzerland
-$67K -34,809 Closed
Two Sigma Investments
31
Two Sigma Investments
New York
-$25K -13,093 Closed
Mariner
32
Mariner
Kansas
-$23K -11,852 Closed
Qube Research & Technologies (QRT)
33
Qube Research & Technologies (QRT)
United Kingdom
-$23K -11,796 Closed
Goldman Sachs
34
Goldman Sachs
New York
-$22K -11,670 Closed
TRCT
35
Tower Research Capital (TRC)
New York
-$11K -5,859 Closed
SPIA
36
Steward Partners Investment Advisory
New York
-$4K -2,200 Closed
PA
37
Parallel Advisors
California
-$1K -464 Closed
CUAMC
38
China Universal Asset Management Company
China
-$1K -332 Closed